A series of associated compounds have been explored by Roche in the 90s, including RO48-6791 and an analogous compound identified as RO48-8684. Neither of those medication ever built it to marketplace. The imidazobenzodiazepine course is made up of a series of compounds that work as equally agonists and inverse agonists to your GABA-A receptors [6